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Abstract 
Background: Intra-arterial chemotherapy (IAC) for oral cancer can deliver a higher 
concentration of anticancer agent into a tumor-feeding artery than intravenous sys-
temic chemotherapy. However, distribution of anticancer agent into several branches 
of the external carotid artery (ECA) in IAC has not demonstrated sufficient treatment 
efficacy. To improve the effectiveness of IAC, the flow distribution of anticancer agent 
into the branches of the ECA in several IAC methods was investigated using computa-
tional fluid dynamics (CFD).
Methods: Patient-specific three-dimensional vessel models were created from CT 
images of 2 patients with tongue cancer. Catheter models were combined with the 
vessel models. Thirty-two models were generated with varying vertical and horizontal 
positions of the catheter tip. With the use of a zero-dimensional resistance model of 
the peripheral vessel network, conventional IAC and superselective IAC were simulated 
in 30 and 2 models, respectively. The flow distribution of anticancer agent into the 
branches of the ECA was investigated in 32 models. Additionally, the blood streamline 
was traced from the inlet of the common carotid artery toward each outlet to examine 
the flow of anticancer agent in all models, and the wall shear stress of the vessel was 
calculated for some models.
Results: The CFD simulations could be conducted within a reasonable computational 
time. In several models, the anticancer agent flowed into the target artery only when 
the catheter tip was located below the bifurcation of the ECA and each target artery. 
Furthermore, the anticancer agent tended to flow into the target artery when the 
catheter tip was shifted toward the target artery. In all ECA branches that had flow of 
anticancer agent, the blood streamlines to the target arteries contacted the catheter 
tip. Anticancer agent flowed into only the target artery in patients’ models for superse-
lective IAC. However, high wall shear stress was observed at the target artery in one 
patient’s model.
Conclusions: This CFD study showed that location of the catheter tip was important 
in controlling the anticancer agent in conventional IAC. The distribution rate of antican-
cer agent into the tumor-feeding artery tended to increase when the catheter tip was 
placed below and toward the target artery. Although superselective IAC can reliably 
supply anticancer agent to the target artery, high wall shear stress at the target artery 
can occur, depending on vessel geometry of the patient, which may cause serious 
complications during the treatment.
Open Access
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and 
indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdo-
main/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
RESEARCH
Kitajima et al. BioMed Eng OnLine  (2017) 16:57 
DOI 10.1186/s12938‑017‑0348‑5 BioMedical Engineering
OnLine
*Correspondence:   
iwai104oams@yahoo.co.jp 
1 Department of Oral 
and Maxillofacial Surgery, 
Yokohama City University 
Graduate School of Medicine, 
3-9 Fukuura, Kanazawa-ku, 
Yokohama 236-0004, Japan
Full list of author information 
is available at the end of the 
article
Page 2 of 26Kitajima et al. BioMed Eng OnLine  (2017) 16:57 
Keywords: Oral cancer, Intra-arterial chemotherapy, Computational fluid dynamics, 
Simulation, Blood flow, External carotid artery and its branches
Fig. 1 Catheterization method for intra-arterial chemotherapy. Three types of intra-arterial infusion are 
shown for a case of cancer of the tongue that is fed by the lingual artery. a Conventional intra-arterial chemo-
therapy via the superficial temporal artery (STA). b Superselective intra-arterial chemotherapy via the femoral 
artery. c Superselective intra-arterial chemotherapy via the STA. ECA external carotid artery, FA facial artery, ICA 
internal carotid artery, MA maxillary artery, OA occipital artery, SThA superior thyroid artery
Background
In the treatment of oral cancer, surgery is considered to be the most effective curative 
modality. However, radical surgery for advanced oral cancer often causes severe oral 
dysfunction—such as disorders of speech, mastication, and swallowing—and results in 
lower quality of life. To preserve organ function, a multidisciplinary approach that com-
bines radiotherapy and chemotherapy has become a viable alternative to radical surgery 
in advanced cases [1, 2].
Intra-arterial chemotherapy (IAC) has been used to treat head and neck cancer since 
the 1950s [1]. In this method, a linear catheter is placed near a target tumor-feeding 
artery originating from the external carotid artery (ECA; Fig.  1a). Intratumoral con-
centrations of anticancer agents therefore fluctuate, and the efficacy of early IAC was 
unproven [1, 3]. Recently, progress in vascular radiological techniques has led to the 
development of superselective IAC (SSIAC), which has the advantage of delivering a 
higher concentration of anticancer agent to the tumor bed than conventional IAC, and 
has been applied to head and neck cancer, including oral cancer [1–3]. SSIAC may be 
delivered via the superficial temporal artery (STA) or femoral artery (Fig. 1b, c) [1, 3], 
and a catheter is inserted into a tumor-feeding artery originating from the ECA, such 
as the lingual artery (LA), facial artery (FA), or maxillary artery (MA). In SSAIC via the 
femoral artery (Seldinger’s method), the catheter is inserted into a branch of the ECA in 
an antegrade fashion by interventional radiologists (Fig. 1b) [1, 3–5]. Because the cath-
eter is inserted through the common carotid artery (CCA) when an anticancer agent is 
injected, severe complications such as cerebral infarction and sudden death have been 
reported, albeit rarely [3–5]. In contrast, SSAIC via the STA does not always require 
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interventional radiologists, and a hook-shaped catheter (Medikit Co., Ltd, Tokyo, Japan) 
can be inserted into the target artery in a retrograde fashion by oral and maxillofacial 
surgeons or otolaryngologists (Fig. 1c) [3, 6, 7]. However, when catheter insertion into 
the target tumor-feeding artery is difficult, the catheter is placed in the ECA and conven-
tional IAC is performed, resulting in unpredictable flow of anticancer agents [6].
In IAC via the STA, the concentration of anticancer agents introduced to branches of 
the ECA is unclear. In our previous study of IAC for patients with tongue cancer [7], con-
centrations of an anticancer agent (carboplatin) were measured in resected tumor tissues 
after IAC and SSIAC. The mean platinum concentration in tumor tissue after IAC was 
about 40% of the amount delivered after SSIAC (4.3 ± 3.8 μg/g wet vs 10.5 ± 1.2 μg/g 
wet, respectively). The standard deviation of platinum concentration after IAC was 
larger and in some cases, the anticancer agent rarely flowed via the LA (tumor-feeding 
artery). This study showed that the concentration of anticancer agent delivered to the 
tumor-feeding artery was more unpredictable after IAC than after SSIAC.
Although it is useful to simulate the distribution of anticancer agent in the ECA for 
each patient, there are few reports on the application of computational fluid dynamics 
(CFD) to IAC analysis in head and neck cancer, including oral cancer [8, 9]. To apply 
CFD as a tool to assist treatment, simulations must be conducted accurately within a 
reasonable computational time. For realistic blood flow simulation, the pressure con-
dition is particularly important because it determines the flow distribution among the 
arteries. In our previous study [9], we developed a model for the outflow boundary con-
dition as a zero-dimensional (0D) resistance model of the peripheral vasculature, which 
consists of only resistance to be incorporated into the commercial three-dimensional 
(3D) flow simulation software. The new 0D model could provide physiological pressure 
at each outlet and allow accurate blood flow simulation in the ECA and its branches. In 
the present study, the boundary condition given in [9] was modified to simulate the flow 
of blood and anticancer agent in the ECA and its branches. The purpose of this CFD 
study was to numerically investigate the flow distribution of anticancer agent into the 
branches of the ECA in several IAC methods with the aim of improving the effectiveness 
of IAC.
Methods
Patient‑specific geometric model
Computed tomography angiography
Patients with oral cancer underwent computed tomography (CT) angiography before 
IAC. We used a 64-slice CT scanner (Aquilion 64; Toshiba Medical Systems, Tokyo, 
Japan), and non-ionic contrast medium (100  mL) was injected at a rate of 4.0  mL/s 
through an antecubital vein with an automatic power injector. A bolus-tracking tech-
nique was used to individually select the scan delay of the arterial phase. Repetitive 
low-dose scans were performed with a delay of 8 s at a level inferior to the carotid bifur-
cation. To measure the bolus arrival time, the region of interest was chosen to lie in the 
CCA. The scanning procedure started automatically when an enhancement level of 90 
Hounsfield units was reached. For the arterial phase scan, the scanning volume included 
the inferior margin of the thyroid cartilage/bottom of C6 and the superior margin of the 
orbit. The scanner settings were 120 kV, 250 mA, slice collimation 64 × 0.5 mm, table 
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speed 20.5 mm/rotation (pitch 0.641), and rotation time 0.75  s. The resolution matrix 
was 512 × 512 pixels with a slice thickness of 1 mm.
We investigated 3D-CT angiography of the ECA and its branches in many patients 
with oral cancer and selected 2 patients with tongue cancer with origins in the LA, FA, 
and occipital artery (OA), which are orthogonal to or aligned with one another in distal 
view of the ECA.
Patient‑specific model
Digital Imaging and Communications in Medicine (DICOM) data from CT angiography 
of the 2 patients with tongue cancer were input into Mimics software (Materialise, Leu-
ven, Belgium). The carotid artery and its branches were segmented, and 2 patient-spe-
cific 3D geometrical models with origins in the LA, FA, and OA were created (Fig. 2a, b). 
The models included the CCA, internal carotid artery (ICA), and ECA branches such as 
the superior thyroid artery (SThA), LA, OA, FA, posterior auricular artery (PAA), mid-
dle meningeal artery (MMA), MA, and STA. Because of CT resolution, model A did not 
include the PAA or MMA. According to our previous study [9], each artery was cut off 
at a length five times its diameter to minimize the influence of boundary conditions on 
the flow distributions. In addition, a 1.3-mm–diameter catheter, which is in clinical use, 
was designed in Standard Triangulated Language (STL) format (Fig.  2c). The catheter 
model was combined with the vessel model for IAC via the STA using Mimics software. 
Thirty-two models were generated with variations in the vertical and horizontal posi-
tions of the catheter tip (Figs. 3, 4; Tables 1, 2).
Mesh generation
Computational grids were created from the surface of the geometrical model. The vol-
ume meshes were generated using ICEM-CFD software (Ansys Inc., Canonsburg, PA) 
for each analysis model. Figure  5 shows the surface and volume meshes of vessel and 
catheter for model A1-C. The mesh consists of tetrahedral cells in the center region 
and prismatic cells in the region near the arterial wall and the catheter wall (Fig. 5a, b, 
respectively). Mesh sensitivity tests were performed for models A1-C and B1-C. For 
mesh sensitivity tests, mass flow rate of the anticancer agent (kg/s) at each outlet was 
compared among different mesh densities ranging from 1,320,913 to 8,072,925 cells 
for model A1-C and from 5,459,786 to 18,971,746 cells for model B1-C. Mesh density 
was adjusted until the mass flow rate of anticancer agent at each outlet was less than 
1.32 × 10‐7 (kg/s) (1.0% of the distribution rate of the anticancer agent). As a result, the 
adopted numbers of cells for models A1-C and B1-C were 5,713,318 and 16,885,069, 
respectively. The same cell sizes for each part in models A1-C and B1-C were applied 
for 15 other models in cases A and B, respectively, and the average number of cells was 
5,424,908 in case A and 16,467,416 in case B. The catheter was assumed to be a hol-
low tube without any inside meshes (Fig. 5c) and the boundary condition of anticancer 
agents was prescribed as the inflow boundary condition, because anticancer agents are 
injected at a constant velocity using a syringe driver and recirculation cannot occur in 
the catheter during intra-arterial infusion.
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Numerical methods
Anticancer agents were assumed to be transported along with the blood. Species trans-
port analysis was conducted using FLUENT software (Ansys Inc.) to simulate the intra-
arterial infusion together with blood flow analysis. The flow fields of the mixture were 
solved using the mass and the momentum conservation equations of incompressible 
single-phase flow, while the flow of the anticancer agent was solved as a function of the 
concentration (mass fraction) of the advection–diffusion Eq. (1) as follows: 
(1)
∂
∂t
(ρm Yi)+ ∇ ·
(
ρm
−→
v Yi
)
= −∇ ·
−→
Fi
Fig. 2 Three-dimensional vessel models and catheter. a Three-dimensional model of the right carotid artery 
and its branches in case A. b Three-dimensional model of the left carotid artery and its branches in case B. c 
Three-dimensional catheter model (diameter: 1.3 mm). ECA external carotid artery, FA facial artery, ICA internal 
carotid artery, LA lingual artery, MA maxillary artery, MMA middle meningeal artery, OA occipital artery, SThA 
superior thyroid artery
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Fig. 3 Classification of vertical position of catheter tip. ECA external carotid artery, FA facial artery, ICA internal 
carotid artery, LA lingual artery, MA maxillary artery, MMA middle meningeal artery, OA occipital artery
Fig. 4 Classification of horizontal position of catheter tip. Target arteries are the lingual, facial, and occipital 
arteries. The catheter tip rotates centering on a point 10 mm away from the tip, and the amount of shift from 
the centerline of the catheter is a quarter of the diameter of the external carotid artery (ECA). Classification of 
horizontal position of catheter tip is determined in distal view of the ECA. LA lingual artery
Table 1 Classification of vertical position of catheter tip
ECA external carotid artery, FA facial artery, LA lingual artery
Class Position of catheter tip
1 Intermediate position between the carotid bifurcation and LA origin (bifurcation between the ECA and 
LA)
2 LA origin (bifurcation between the ECA and LA)
3 Intermediate position between the LA origin and FA origin (bifurcation between the ECA and FA)
4 Catheter insertion into the LA (superselective intra-arterial catheterization)
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where Y is the concentration (mass fraction) of the species, subscript i indicates the spe-
cies number, and species numbers 0 and 1 represent the anticancer agent and blood, 
respectively. The concentration of the anticancer agent (Y0) was calculated from Eq. (1). 
As the sum of the mass fractions of the species is always 1, the concentration of blood 
(Y1) is calculated as the difference between 1 and Y0. ρm is the density (kg/m3) of the mix-
ture and is described below. Fi is the diffusion flux of the species caused by the concen-
tration gradient. Dilute approximation (Fick’s law) was used to model the mass diffusion 
caused by the concentration gradient, and the diffusion flux is expressed in Eq. (2) on the 
basis of the following approximation:
where Di,m is a diffusion coefficient  (m2/s) of species i in the mixture. In this study, the 
anticancer agent was assumed to be a continuum of water. Although there is currently 
no report on the measurement values of the diffusion coefficient of water or of the anti-
cancer agent to blood, diffusion coefficients between liquids are reported in the order of 
approximately 0.25 × 10−9 to 4.56 × 10−9 m2/s at temperatures of 8–30 °C [10]. In this 
study, the self-diffusion coefficient of water at 25 °C (2.299 × 10−9 m2/s) [11] was used 
as the diffusion coefficient of water to blood. The density (ρm) and viscosity (μm) of the 
mixture were defined as functions (3) and (4) of the mass fraction of species i:
Regarding the physical properties of each species, the anticancer agent has a density 
(ρ0) and viscosity (μ0) of 998.2 kg/m3 and 0.0010 Pa s, respectively, whereas the values for 
blood (ρ1 and μ1) are 1050.0 kg/m3 and 0.0046 Pa s, respectively. In this study, the viscos-
ity of blood (μ1) was considered constant within the 3D analysis domain, whereas μ1 was 
defined by hematocrit and the diameters of the blood vessels in the 0D resistance model 
used for the outlet boundary conditions (see Sect. "Modeling blood viscosity").
(2)−→Fi = − ρm Di,m ∇ Yi
(3)ρm =
1∑
i
Yi
ρi
(4)µm =
∑
i
Yiµi
Table 2 Classification of horizontal position of catheter tip
Target arteries are the lingual, facial, and occipital arteries. Catheter tip rotates centering on a point 10 mm away from the 
tip, and the amount of shift from the centerline of the catheter is a quarter of the diameter of the external carotid artery 
(ECA). Classification of horizontal position of catheter tip is determined in distal view of the ECA
Class Position of catheter tip
C Center of the ECA
F Forward shift of catheter tip toward the target artery from center of the ECA
B Backward shift of catheter tip toward the target artery from center of the ECA
L Left shift of catheter tip toward the target artery from center of the ECA
R Right shift of catheter tip toward the target artery from center of the ECA
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In practice, anticancer agents are injected through the catheter for 1 h at a constant 
velocity using a syringe driver. Because this study focused on the average flow distribu-
tion of the anticancer agent to the arteries, steady-state fluid dynamics simulations using 
the finite volume FLUENT software were performed without the pulsation of blood flow. 
A double-precision solver was utilized for all models. A SIMPLE (Semi-Implicit Method 
for Pressure-Linkage Equations) scheme was used to couple velocity and pressure, and 
the discretization was accurate to the second order. The 0D resistance model, which we 
previously developed for the outflow boundary condition [9], was used as input data 
for user-defined functions in the code. The convergence of the simulations was verified 
Fig. 5 Surface and volume mesh for model A1-C. a The surface mesh of the vessel and catheter for model 
A1-C. The wall of the ECA is hidden. b The surface mesh of the vessel. c The volume mesh of the vessel. Cross-
sectional view of the dot-line in b. ECA external carotid artery, FA facial artery, ICA internal carotid artery, LA 
lingual artery, MA maxillary artery, MMA middle meningeal artery, OA occipital artery
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by monitoring the mass flow rate (kg/s) of the anticancer agent at each outlet, and was 
achieved when the monitored value showed oscillations of the order of  10−9 or less.
Fluid dynamic simulations were performed on a PC running the Microsoft Windows 
7 Professional operating system (Microsoft Corp., Redmond, WA). The CPU was a dual-
core Intel Xeon W5590 (clock frequency: 3.33 GHz), and there were 64 GB of RAM per 
core. Serial computing with one core for model A and parallel computing with 4 cores 
for model B were performed because model B has a larger number of cells than model A.
Mathematical modeling of the outflow boundary conditions
Geometrical modeling of the peripheral vessel network
Because the flow of the anticancer agent is affected by blood flow in the ECA, accurate 
blood flow is required in the 3D model. To achieve this, we developed a boundary con-
dition for the 0D resistance model to simulate blood flow in the ECA and its branches 
[9], which assumed a peripheral vessel network. In preliminary analyses, the flow of the 
anticancer agent was simulated in models A1-C and B1-C without the outflow bound-
ary condition. In the analyses, zero-pressure was given at each outlet. The simulation 
result was compared with that when using the 0D resistance model. The mass flow rates, 
distribution rates of the anticancer agent at each outlet (ECA branch) with two outflow 
boundary conditions, and resistance values in the 0D model are shown in Tables 3 and 4. 
Because there were different results between the two outflow boundary conditions and 
it has been demonstrated that the 0D resistance model can provide accurate outlet pres-
sure (see Ohhara [9]), we decided to use the 0D resistance model for this study.
Because the resolution of CT or magnetic resonance imaging is not sufficient for accu-
rate geometric modeling of a peripheral blood vessel network with small arteries, arteri-
oles, and capillaries, the peripheral network was constructed by self-similarity geometry. 
The parent blood vessel of generation j has diameter dj, and the flow rate qj is divided 
into 2 branches in 2 daughter generations (j + 1, 1) and (j + 1, 2), as shown in Fig. 6. 
The peripheral network is categorized into 6 groups according to vessel diameter, as 
described in [9]: (1) ICA, (2) large arteries, (3) main artery branches, (4) terminal artery 
branches, (5) arterioles, and (6) capillaries (Table 5).
0D resistance model
Similar to our previous study [9], we defined the ratio of vessel length to vessel radius 
λ = l/r, where l is the length and r is the radius of a blood vessel. We can express the rela-
tionship between the pressure drop and flow rate in the time domain as follows:
where P, Q, and R denote the pressure, quantity of flow, and resistance, respectively. The 
suffix n denotes the nth generation of bifurcation.
The resistance model consisted of two steps. The first was calculation of the resistance 
Rj (0) at the inlet of the artery of the jth generation:
(5)Pn(L)
Qn(L)
= Rn(L)
(6)Rj(0) =
8µm(
pir3j
) + Rj(L)
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where μm is the viscosity of the mixture of the anticancer agent and blood as described 
later, λ is the ratio of the vessel length to its radius, and Rj (L) is the resistance at the out-
let of the jth generation, in which L is the distance from the inlet to the outlet of the jth 
generation.
Table 3 Mass flow rate (×10−6 kg/s), distribution rate of the anticancer agent, and resist-
ance value (mmHg/kg/s) in model A1-C
ICA internal carotid artery, LA lingual artery, MA maxillary artery, MMA middle meningeal artery, OA occipital artery, SThA 
superior thyroid artery
Artery A1‑C
Mass flow rate  
with 0D model
Mass flow rate  
without 0D model
Resistance value 
in 0D model
ICA 0 (0%) 0 (0%) 17,790
SThA 0 (0%) 0 (0%) 386,370
LA 0 (0%) 0.2 (1.5%) 276,843
OA 0 (0%) 0.1 (0.8%) 320,828
FA 9.2 (69.7%) 12.6 (95.5%) 139,474
MA 4.0 (30.3%) 0.3 (2.3%) 313,216
Table 4 Mass flow rate (×10−6 kg/s), distribution rate of the anticancer agent, and resist-
ance value (mmHg/kg/s) in model B1-C
ICA internal carotid artery, FA facial artery, LA lingual artery, MA maxillary artery, MMA middle meningeal artery, OA occipital 
artery, PAA posterior auricular artery, SThA superior thyroid artery
Artery B1‑C
Mass flow rate  
with 0D model
Mass flow rate  
without 0D model
Resistance value 
in 0D model
ICA 0 (0%) 0 (0%) 19,432
SThA 0 (0%) 0 (0%) 293,588
LA 7.5 (56.8%) 11.1 (84.1%) 121,408
OA 0 (0%) 0.1 (0.8%) 155,639
FA 1.6 (12.1%) 1.4 (10.6%) 98,513
PAA 0.3 (2.3%) 0.2 (1.5%) 508,917
MA 0.3 (2.3%) 0.4 (3.0%) 105,510
MMA 3.5 (26.5%) 0 (0%) 1,742,672
Fig. 6 Vessel diameter and quantity of flow in peripheral network. As the parent vessel bifurcates into 2 
daughter vessels, the number of generations increases. The parent blood vessel of generation j has diameter 
dj, and the flow rate qj is equally divided into 2 branches
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The second step was computation of the resistance Rj (L) at the outlet of the artery of 
the jth generation:
The peripheral network was categorized into 6 groups based on vessel diameter and 
length, as previously described, and the average value of λ for each group was deter-
mined. If the radius of the artery at the jth generation indicated that the vessel was in the 
kth group, λj was given by the value of λ for the kth group as shown in Table 5. Moreover, 
the terminal resistance was given by:
Equation (8) allowed us to update the terminal resistance at every step to match the 
physiological conditions of Pterminal. The terminal minimum radius of the model was 
defined as 12 μm, and the pressure was set at 30 mmHg (Fig. 7) based on the findings of 
our study [9].
In the previous study [9], we performed blood flow simulation using the 0D resistance 
model and considered the viscosity of blood as the viscosity of the model. However, in 
the present study, the mixture of blood and anticancer agent was simulated and there-
fore the viscosity in our resistance model depended on the composition of the blood and 
anticancer agent as defined by formula (4). Moreover, assuming that the mass fraction of 
the anticancer agent (Y0) and the blood (Y1 = 1−Y0) were constant in the 0D resistance 
model, Y0 and Y1 were treated with only one value. As preliminary analyses, the antican-
cer agent was simulated in A1-C and B1-C using the two conditions below:
1. The averaged nodal value of Y0 at each outlet was used for Y0 in the 0D resistance 
model.
2. Y0 was not considered in the 0D resistance model. In this condition, the fluid in the 
0D model was treated as blood, and the μapp detailed in Sect. "Modeling blood vis-
cosity" was used for viscosity.
When comparing the simulation results under the two conditions, there were few dif-
ferences at each outlet into which the anticancer agent flowed. Therefore, we decided to 
use the average Y0 nodal value.
(7)Rj(L) = 1
2
Rj+1,1(0)
(8)Rn (L)terminal = PterminalQn (L)terminal
Table 5 Diameter, length, and  ratio of  vessel length to  vessel radius (λ) of  each vessel 
in present peripheral network
Blood vessel Mean diameter (mm) Min. diameter (mm) Length (mm) λ
Internal carotid artery 5.4834 4 117.3925 50.0154
Large arteries 6.5 2 200 61.5385
Main artery branches 2.4 1.2 100 83.3333
Terminal artery branches 1.2 0.1 10 16.6667
Arterioles 0.1 0.015 2 40
Capillaries 0.008 0.004 1 250
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Modeling blood viscosity
In large and medium arteries (3D region), blood behaves as an incompressible Newto-
nian fluid. In contrast, blood exhibits non-Newtonian behavior in small branches and 
capillaries [9, 12]. To take into account non-Newtonian effects, the apparent viscosity is 
given as a function of both the diameter and the hematocrit [13–16]. First, the hemato-
crit is given by
where d is the vessel diameter.
When the vessel diameter is smaller than 10 μm, the apparent viscosity decreases in 
accordance with the Fåhraeus–Lindqvist effect. By the inverse Fåhraeus–Lindqvist 
effect, the apparent viscosity increases when the vessel diameter is larger than a certain 
value. Equation (9) incorporates both effects.
The red line in Fig.  8 shows the behavior of apparent viscosity in this study, which 
matches that in previous studies [16, 17]. We used Eq. (10), which was proposed by Pries 
et al. [17, 18], to obtain the following relationship between the viscosity μapp and vessel 
diameter d.
where
(9)Hct =
{
0.45
0.45(0.196 log d − 0.117)
if
if
d > 300µm
d ≤ 300µm
(10)µapp =
[
1+
(
µapp − 1
) (1−Hct)cd − 1
(1− 0.45)cd − 1
(
d
d − 1.1
)2]( d
d − 1.1
)2
(11)Cd = (0.8+ exp [−0.075d])
(
−1+
1
1+ 10−11d12
)
+
1
1+ 10−11d12
Fig. 7 Data passing between three-dimensional outlet and zero-dimensional resistance model. Outlet pres-
sure is calculated according to the mass flow rate at each outlet in the 3D outlet. The mass fraction of anti-
cancer agent and blood are both constant. The viscosity of blood is defined as a function of vessel diameter 
and hematocrit. 0D zero-dimensional, 3D three-dimensional, ICA internal carotid artery
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and
When μ (the viscosity of the hematocrit) is 0.45, μNewtonian is considered to be 
4.06 × 10−3 (Pa s). In the 0D resistance model, μapp was substituted for μ1 in formula (4).
Numerical conditions
Each analysis model has 2 velocity inlets (the inlet of the CCA and the catheter tip) and 6 
or 8 pressure outlets. Considering the inflow boundary conditions, the blood flow veloc-
ity at the CCA was measured by ultrasonography in each patient before catheterization. 
The mean velocities were obtained by averaging 4 consecutive cardiac cycles and were 
0.38  m/s in case A and 0.43  m/s in case B. The velocity distributions were calculated 
using the Poiseuille flow. A uniform distribution velocity was calculated from the flow 
rate given at an administration rate of 50  mL/h with a syringe driver and a 1.30-mm 
diameter catheter tip during actual intra-arterial infusion, and a velocity of 0.01 m/s was 
prescribed at the catheter tip. The Reynolds number at the catheter tip is 13 in both 
models. The Reynolds number at the inlet of the CCA is 564 in model A and 664 in 
model B. Therefore, both flow of the anticancer agent and flow of blood were assumed as 
laminar flows. The mass fraction of the anticancer agent (Y0) was set as 1 at the catheter 
tip and 0 at the inlet of the CCA. In the wall boundary conditions, both the vascular and 
catheter walls were regarded as rigid and the no-slip condition was applied. In the outlet 
boundary conditions, the 0D resistance model described above was applied to each of 
the outlets, including the ICA and branches of the ECA. Because the STA is ligated with 
the catheter during the catheterization, neither the blood nor anticancer agent flows into 
the STA; therefore, the STA outlet was treated as a wall surface.
(12)µ0.45 = 6 exp [−0.085d]+ µNewtonian − 2.44 exp
[
−0.06d0.645
]
Fig. 8 Change in apparent viscosity of blood with diameter of the vessel
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Wall shear stress
Wall shear stress was (WSS) calculated using CFD, and WSSs of the vessels (LA and 
carotid bifurcation) and catheter in IAC models (A1-C, B1-C) and SSIAC models (A4, 
B4) were evaluated.
Results
The simulations of vessel models A and B took approximately 40 h and 43 h to complete, 
respectively. The mass flow rates and distribution rates of the anticancer agent at each 
outlet (ECA branch) in 32 models are summarized in Tables 6 and 7. Figures 9 and 10 
show the distribution rates of the anticancer agent on vessel images. Figures 11 and 12 
show the flow of the anticancer agent in several models for the 2 cases. In several models 
for conventional IAC, the anticancer agent flowed into each target branch only when the 
catheter tip was located below the bifurcation between the ECA and each target branch. 
Furthermore, the anticancer agent tended to flow into the target branch when the cath-
eter tip was shifted toward the target branch. In contrast, in models for SSIAC (models 
A4 and B4), the total amount of anticancer agent from the catheter tip flowed into the 
target artery.
To examine the flow of the anticancer agent in all models, the blood streamlines were 
traced from the inlet of the CCA toward each outlet. The streamlines of 4 models for 
model B are shown in Figs. 13 and 14. In all ECA branches that had flow of anticancer 
agent, the blood streamlines to the target branches contacted the catheter tip.
In models A1-LA (F), B1-C, B1-LA (F), and B1-LA (L) with flow of anticancer agent 
into the LA, blood streamlines toward the LA contact the catheter tip. In contrast, in 
model B1-LA (B), which did not show a flow of anticancer agent into the LA, the blood 
streamline toward the LA did not contact the catheter tip. Flow of anticancer agent to 
the OA was revealed in models A1-OA (F), A2-OA (F), B1-OA (F), and B2-OA (F). Anti-
cancer agent flowed into the LA or OA only when the catheter tip was placed below the 
origin of each tumor-feeding artery, and it tended to flow into the target branch when 
the catheter tip was shifted toward the target branch. In contrast, flow of anticancer 
agent to the FA was shown in most models (27 of 30) for conventional IAC. In class 
C with the catheter placed at the center of the ECA, class 3 in which the vertical posi-
tion of the catheter tip was closest to the origin of the FA provided high distribution 
rates (72.7–80.3%) of anticancer agent in both models A and B. Moreover, forward and 
backward shifts of the catheter tip in relation to the FA provided distribution rates of 
anticancer agent that were high (84.8–100%) and low (0–13.6%), respectively. However, 
unlike in simulations of anticancer agent flow into the LA and OA, the distribution rate 
of anticancer agent to the FA tended to increase as the vertical position of the catheter 
tip became closer to the origin of the FA when the tip was shifted right or left toward the 
FA; the mean distribution rates in classes 1-3 were 45.1% (range, 0–78.8%), 76.4% (range, 
44.7–98.5%), and 87.3% (range, 55.3–99.2%), respectively.
Figures 15 and 16 show WSSs of the vessel and catheter in models A1-C, A4, B1-C, 
and B4. In models A1-C and A4, the WSS values of the LA were 21.1 and 154.0  Pa, 
respectively. In models B1-C and B4, the WSS values of the LA were 12.7 and 22.7 Pa, 
respectively. The WSS values of the carotid bifurcation, which is the site of predilection 
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for arteriosclerosis, in models A1-C, A4, B1-C, and B4 were 9.5, 9.9, 17.3, and 17.2 Pa, 
respectively. 
Discussion
Common feeding arteries of oral cancer include the LA, FA, and MA, which are 
branches of the ECA. Generally, a blue dye such as indigo carmine is manually injected 
to confirm whether the catheter is properly placed in the ECA in the vicinity of the 
Fig. 9 Distribution rates of the anticancer agent at each outlet in model A. ECA external carotid artery, FA 
facial artery, ICA internal carotid artery, LA lingual artery, MA maxillary artery, MMA middle meningeal artery, 
OA occipital artery
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tumor-feeding artery during catheterization or when IAC is performed. However, the 
high pressure created by manual injection can cause dye to reach the tumor even if 
the catheter is displaced from the origin of the tumor-feeding artery [3]. Administra-
tion of anticancer agents is performed not with a manual one-shot injection involving 
high pressure, but with a bolus or continuous infusion using a syringe driver; therefore, 
anticancer agents injected into the ECA may not reach the tumor-feeding artery [3]. 
Fig. 10 Distribution rates of the anticancer agent at each outlet in model B. FA facial artery, ICA internal 
carotid artery, LA lingual artery, MA maxillary artery, OA occipital artery
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The efficacy of conventional IAC for oral cancer is thus unproven and is not universally 
accepted [1, 3].
Because the tumor-feeding artery of maxillary sinus cancer or gingival cancer is the 
MA with/without the FA, the tip of the catheter is placed via the STA, mainly below the 
origin of the MA and occasionally below the origin of the FA. Catheterization below the 
origin of the MA in IAC allows anticancer agent flow to the MA that is similar to that in 
SSIAC because the catheter is ligated with the STA. Therefore, the present CFD study 
focused on the distribution of flow of anticancer agent into the branches of the ECA, 
excluding the MA, using several catheter positions for IAC.
To date, there have been few patient-specific blood flow simulations for IAC of head 
and neck cancer, including oral cancer. Rhode et al. [8] reported a simulation of hemo-
dynamic flow in IAC using Seldinger’s method for head and neck cancer. Although a 
patient-specific vessel model was created from CT images, branches of the ECA, such as 
the OA, MA, and STA, were not created and a common trunk (linguofacial trunk), which 
is not a typical branch shape of the ECA [9, 19–21], was used. Furthermore, the catheter 
was placed at the CCA, which is not done in clinical practice, and the distribution rates 
Fig. 11 Volume rendering images of the mass fractions of the anticancer agent in model A. Branches of the 
external carotid artery (ECA) with flow of anticancer agent are shown in yellow type. FA facial artery, ICA inter-
nal carotid artery, LA lingual artery, MA maxillary artery, OA occipital artery, SThA superior thyroid artery
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of the blood flow, which were derived from other studies, were fixed at each outlet as the 
boundary condition, and the peripheral vascular network was not considered. Therefore, 
their CFD analysis was not conducted in a patient-specific manner and no physiological 
pressure was provided.
The present CFD study applied patient-specific vessel models from CT images and 
a 0D resistance model, with estimation of vessel pressure and flow distribution as a 
boundary condition, for patients with tongue cancer fed by the LA. Only model LA (F) 
in class 1 of model A allowed flow of the anticancer agent into the LA. However, flow of 
the anticancer agent was observed in three models in class 1 of model B. In particular, 
all anticancer agents injected from the catheter flowed into the LA in models B1-LA (F) 
and B1-LA (L). Flow of anticancer agent to the OA was revealed in models A1-OA (F), 
A2-OA (F), B1-OA (F), and B2-OA (F). Anticancer agent flowed into the LA or OA only 
when the catheter tip was placed below the origin of each tumor-feeding artery, and it 
tended to flow into the target branch when the catheter tip was shifted toward the target 
branch. As shown in Fig. 14, the present CFD study revealed that the anticancer agent 
can flow into the tumor-feeding artery in conventional IAC when the blood streamline 
toward the tumor-feeding artery from the CCA contacts the catheter tip. These IAC 
simulation results suggest that the catheter tip should be placed both below and toward 
the target artery to increase the distribution rate of anticancer agent into the LA and 
Fig. 12 Volume rendering images of the mass fractions of the anticancer agent in model B. Branches of the 
external carotid artery (ECA) with flow of anticancer agent are shown in yellow type. FA facial artery, ICA inter-
nal carotid artery, LA lingual artery, MA maxillary artery, MMA middle meningeal artery, OA occipital artery, PAA 
posterior auricular artery, SThA superior thyroid artery
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Fig. 13 Blood streamline to target branches of the external carotid artery in model B1-C. Blood flow 
throughout the whole arterial system is shown by streamline. ECA, external carotid artery; FA, facial artery; 
ICA internal carotid artery, LA lingual artery, MA maxillary artery, MMA middle meningeal artery, OA occipital 
artery, STA superficial temporal artery, SThA superior thyroid artery
Fig. 14 Blood streamline to target branches of the external carotid artery in model B. Blood flow to target 
branches (red type) is shown by streamline. ECA external carotid artery, FA facial artery, ICA internal carotid 
artery, LA lingual artery, OA occipital artery
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OA. In contrast, flow of anticancer agent to the FA was shown in most models for con-
ventional IAC. However, contrary to flow simulations of anticancer agent into the LA 
and OA, the distribution rate of anticancer agent to the FA tended to increase as the ver-
tical position of the catheter tip became closer to the origin of the FA when the tip was 
shifted right or left toward the FA. Because the cross-sectional area of the ECA gradually 
decreases toward peripheral arteries, such as the STA, and the blood streamline toward 
the FA from the CCA tends to contact the catheter tip, the distribution rate of antican-
cer agent to the FA tends to increase as the catheter tip becomes closer to the origin of 
the FA.
Branches of the ECA have anatomical variations, including the common trunk or the 
order of branch origins. The respective incidence of thyrolingual trunk and linguofacial 
trunk has been reported as 0.7–3% [19–21] and 2.7–31% [19–22]. In a cadaver study, 
Yonenaga et al. [21] reported the incidence of order of the ECA branches (observed from 
the caudal side) as follows: (1) LA, FA, and OA in 41.1% of cases; (2) LA, OA, and FA 
in 17.6%; (3) OA, LA, and FA in 7.1%; (4) linguofacial trunk and OA in 21.4%; (5) OA 
and linguofacial trunk in 10.7%; and (6) thyrolingual trunk, FA, and OA in 1.9%. In the 
present study, the order of ECA branches in both model A and model B (from the caudal 
side) was LA, OA, and FA. The present flow simulation suggests that flow distribution 
Fig. 15 Wall shear stress distribution in models A1-C and A4. FA facial artery, ICA internal carotid artery, LA 
lingual artery, MA maxillary artery, OA occipital artery, STA superficial temporal artery, SThA superior thyroid 
artery
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of anticancer agent into the FA might decrease when the FA originates from the ECA 
between the LA and OA, because the cross-sectional area of the ECA increases as the 
origin of the FA becomes closer to the carotid bifurcation and the blood streamline 
toward the FA from the CCA tends not to contact the catheter tip. However, the distri-
bution rate of anticancer agent into the FA may be increased by placement of a curved 
catheter tip both below and toward the target artery.
Wall shear stress is associated with endothelial function and is calculated by CFD. For 
an oral cancer patient, Rhode et  al. [8] simulated the WSS of the CCA bifurcation in 
the case of Seldinger’s method using CFD. The WSS of the carotid bifurcation found 
this way was high (80 Pa) because the catheter was placed at the CCA below the carotid 
bifurcation and injection velocity was high (2.5 mL/s). Because high WSS can potentially 
cause acute vascular endothelial changes, the present study evaluated WSSs in IAC and 
SSIAC models. The WSS of the LA in model A4 (154.0 Pa) was much higher than that 
in model A1-C (21.1 Pa) because reduction of blood flow into the small-diameter LA by 
Fig. 16 Wall shear stress distribution in models B1-C and B4. FA facial artery, ICA internal carotid artery, LA 
lingual artery, MA maxillary artery, OA occipital artery, STA superficial temporal artery, SThA superior thyroid 
artery
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insertion of the catheter caused a large velocity gradient of the flow near the catheter. As 
the acute yield stress of the vessel is reported to be approximately 37.9 Pa [23], SSIAC 
may cause acute vascular endothelial changes at the LA in case A. In contrast, the WSS 
values of the LA were less than 37.9 Pa in both models B1-C and B4 (12.7 and 22.7 Pa, 
respectively). This is because the diameter of the LA (about 3.0 mm) was larger than in 
case A. Therefore, conventional IAC, as well as SSIAC, may not cause acute vascular 
endothelial changes at the LA in case B. This WSS simulation can allow the method of 
catheter placement to be selected preoperatively to avoid damaging the tumor-feeding 
artery with the catheter.
There were some limitations in the present study. This study assumed a healthy blood 
vessel, but angiogenesis has been observed in regions of tumor progression. Therefore, 
it may be not reasonable to assume that the parameters of vessels in the tumor region 
are similar to those of healthy blood vessels and further studies should be performed in 
the future. Pulsatile flow simulation with unsteady analysis is also needed to simulate 
distribution of the anticancer agent and WSS of the ECA for the whole duration of infu-
sion (1 h). Furthermore, the vascular wall was considered to be a no-slip rigid wall in this 
study. Because vascular elasticity can affect the flow of blood and anticancer agent in 
actual IAC, fluid structure interaction analysis is necessary to account for the elasticity 
of the vessel walls and catheter movement. Only two patient-specific datasets were used 
in this study, so additional simulation with more patients’ data will be needed to under-
stand the characteristics of anticancer agent flow in the ECA branches of patients.
Conclusions
We numerically investigated the flow distribution of anticancer agent into the branches 
of the ECA in IAC models. The CFD simulation results of IAC showed that a curved 
catheter tip may be placed both below and toward the target artery to increase the distri-
bution rate of anticancer agent into the tumor-feeding artery. Although SSIAC can reli-
ably supply anticancer agent to the target artery, high WSS at the target artery can occur, 
depending on vessel geometry of the patient, and this may cause serious complications 
during treatment. In future study, analysis of the fluid structure interaction is necessary 
to account for the elasticity of the vessel walls and catheter movement in many patient 
models.
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